An Upper Extremity Exoskeleton to Target Unwanted Joint Synergies During Repetitive Training in Stroke Survivors
NCT ID: NCT05962697
Last Updated: 2025-08-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2024-08-03
2025-08-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Robotic Training for Stroke Neurorehabilitation
NCT02639390
Evaluation of Robotic Arm Rehabilitation in Stroke Patients
NCT00333983
Neural Mechanisms of Motor Recovery With Technology Assisted Training
NCT05560867
Extension of the MIME Robotic System for Stroke Rehabilitation
NCT00995774
Ankle Robotics Training After Stroke
NCT01337960
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SA controller
Synergy assistance controller
SA controller
Novel controller to be tested
TA controller
original controller to be tested
early testing
up to 5 participants testing the SA controller in one visit
SA controller early testing
Novel controller to be tested early testing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SA controller
Novel controller to be tested
TA controller
original controller to be tested
SA controller early testing
Novel controller to be tested early testing
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* have a Fugl-Meyer Upper Extremity score of 29-42 for moderately impaired (aim 1) or 0-28 for severely impaired (aim 1 and 2),
* have body dimensions within the limits of the Harmony system
* suffered a stroke within the past 1-6 months (aim 1) or 1 week (aim 2)
Exclusion Criteria
* unstable cardiovascular, orthopedic, or neurological conditions,
* a history of seizure,
* significant communication deficits,
* severe upper-limb joint pain or limitations that would restrict their ability to complete the protocols,
* inadequate cognitive or language function to consent or to participate, and (7) no phone number or stable mailing address.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brittney C Muir, PhD
Role: PRINCIPAL_INVESTIGATOR
VA Puget Sound Health Care System Seattle Division, Seattle, WA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Puget Sound Health Care System Seattle Division, Seattle, WA
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RZ004631
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
A4631-P
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.